Unknown

Dataset Information

0

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.


ABSTRACT: Infant gliomas have paradoxical clinical behavior compared to those in children and adults: low-grade tumors have a higher mortality rate, while high-grade tumors have a better outcome. However, we have little understanding of their biology and therefore cannot explain this behavior nor what constitutes optimal clinical management. Here we report a comprehensive genetic analysis of an international cohort of clinically annotated infant gliomas, revealing 3 clinical subgroups. Group 1 tumors arise in the cerebral hemispheres and harbor alterations in the receptor tyrosine kinases ALK, ROS1, NTRK and MET. These are typically single-events and confer an intermediate outcome. Groups 2 and 3 gliomas harbor RAS/MAPK pathway mutations and arise in the hemispheres and midline, respectively. Group 2 tumors have excellent long-term survival, while group 3 tumors progress rapidly and do not respond well to chemoradiation. We conclude that infant gliomas comprise 3 subgroups, justifying the need for specialized therapeutic strategies.

SUBMITTER: Guerreiro Stucklin AS 

PROVIDER: S-EPMC6761184 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.

Guerreiro Stucklin Ana S AS   Ryall Scott S   Fukuoka Kohei K   Zapotocky Michal M   Lassaletta Alvaro A   Li Christopher C   Bridge Taylor T   Kim Byungjin B   Arnoldo Anthony A   Kowalski Paul E PE   Zhong Yvonne Y   Johnson Monique M   Li Claire C   Ramani Arun K AK   Siddaway Robert R   Nobre Liana Figueiredo LF   de Antonellis Pasqualino P   Dunham Christopher C   Cheng Sylvia S   Boué Daniel R DR   Finlay Jonathan L JL   Coven Scott L SL   de Prada Inmaculada I   Perez-Somarriba Marta M   Faria Claudia C CC   Grotzer Michael A MA   Rushing Elisabeth E   Sumerauer David D   Zamecnik Josef J   Krskova Lenka L   Garcia Ariza Miguel M   Cruz Ofelia O   Morales La Madrid Andres A   Solano Palma P   Terashima Keita K   Nakano Yoshiko Y   Ichimura Koichi K   Nagane Motoo M   Sakamoto Hiroaki H   Gil-da-Costa Maria Joao MJ   Silva Roberto R   Johnston Donna L DL   Michaud Jean J   Wilson Bev B   van Landeghem Frank K H FKH   Oviedo Angelica A   McNeely P Daniel PD   Crooks Bruce B   Fried Iris I   Zhukova Nataliya N   Hansford Jordan R JR   Nageswararao Amulya A   Garzia Livia L   Shago Mary M   Brudno Michael M   Irwin Meredith S MS   Bartels Ute U   Ramaswamy Vijay V   Bouffet Eric E   Taylor Michael D MD   Tabori Uri U   Hawkins Cynthia C  

Nature communications 20190925 1


Infant gliomas have paradoxical clinical behavior compared to those in children and adults: low-grade tumors have a higher mortality rate, while high-grade tumors have a better outcome. However, we have little understanding of their biology and therefore cannot explain this behavior nor what constitutes optimal clinical management. Here we report a comprehensive genetic analysis of an international cohort of clinically annotated infant gliomas, revealing 3 clinical subgroups. Group 1 tumors aris  ...[more]

Similar Datasets

| S-EPMC9243239 | biostudies-literature
| S-EPMC5653525 | biostudies-literature
| S-EPMC5475194 | biostudies-literature
| S-EPMC4853728 | biostudies-literature
| S-EPMC6688997 | biostudies-literature
| S-EPMC7269872 | biostudies-literature
| S-EPMC4850130 | biostudies-literature
| S-EPMC7362646 | biostudies-literature
| S-EPMC4707106 | biostudies-literature
| S-EPMC4384213 | biostudies-literature